Switch to:
GuruFocus has detected 2 Warning Signs with Valeant Pharmaceuticals International Inc $VRX.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
Valeant Pharmaceuticals International Inc (NYSE:VRX)
Accounts Payable & Accrued Expense
$3,379 Mil (As of Mar. 2017)

Valeant Pharmaceuticals International Inc's quarterly accounts payable & accrued expense declined from Sep. 2016 ($3,751 Mil) to Dec. 2016 ($2,809 Mil) but then increased from Dec. 2016 ($2,809 Mil) to Mar. 2017 ($3,379 Mil).

Valeant Pharmaceuticals International Inc's annual accounts payable & accrued expense increased from Dec. 2014 ($2,144 Mil) to Dec. 2015 ($2,893 Mil) but then declined from Dec. 2015 ($2,893 Mil) to Dec. 2016 ($2,809 Mil).


Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

Valeant Pharmaceuticals International Inc Annual Data

Accounts Payable & Accrued Expense 3182182155537961,2361,8682,1442,8932,809

Valeant Pharmaceuticals International Inc Quarterly Data

Accounts Payable & Accrued Expense 2,1442,7773,4713,7702,8933,7763,7613,7512,8093,379
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat